Since questions have been raised regarding the specificity of some anti-FasL antibodies (Stokes et al, 1998), FasL expression was confirmed by immunohistochemistry on consecutive tumour sections using two different FasL-specific antibodies (clone G247-4, PharMingen; clone C20, Santa Cruz Biotechnology). This evidence concerns the gene FASLG and neoplasm.